Merck to increase workforce at Indian sites by year end

Drug Maker Merck expects to boost employment in India with increment in its workforce across its India sites by the end of the year, a senior executive of the company said.

At the BioAsia conference in India’s Telangana state, Dave Williams, Executive Vice President said, “By the end of this year, we expect to have roughly 2,700 employees. And in a couple of years, I fully expect we’ll double that number or more.”

Merck’s India sites, which together employ around 1,800 people, focus on multiple therapy areas including oncology, diabetes, vaccines and animal health, as well as technology-related centers.
The U.S. drugmaker opened a new technology center in the southern Indian city of Hyderabad this week, Reuters reported.
Read also: Merck gets positive EU CHMP opinion for Pneumococcal vaccination in adults
Williams, who heads the information and digital department, said the company is looking to hire “digital innovators” who can help business partners understand the role technology can play in reducing the time taken to get new treatments to patients.

Read also: Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Facebook Comments